A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every ...

A diabetes drug called dapagliflozin may help prevent heart failure in people with genetic variants linked to cardiomyopathy, ...

Teplizumab, also known as Tzield and made by Sanofi, is approved for children aged 8 and over and adults who have early-stage type 1 diabetes before symptoms appear. It has been proven to slow down ...

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the ...

Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...

Emerging diabetes therapies are transforming MASLD treatment by addressing both metabolic dysfunction and liver disease, with new approvals and a growing pipeline signaling a shift in care. A rapidly ...

This article is part of “Innovations In: Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. More than one in seven people in the U.S. have ...

A diabetes drug was linked to a surprising effect on the risk of dementia.

After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...

Going into 2026, widespread shortages of most major diabetes medications had largely stabilized: The shortages of Humulin and lispro insulin vials, and therefore medications, that dogged ...